In December 2024, Western Europe’s PV selling rate continued its upward trend, reaching 13.1 million units/year. Year-on-year ...

GlobalData predicts that six late-stage pipeline products are set to enter the glaucoma market during the forecast period.

GlobalData has named heart failure as the next disease to feel the sales-boosting power of GLP-1 drugs. The analysts expect ...

A ccording to preliminary estimates, Light Vehicle (LV) sales grew by 2.4% year-on-year (YoY) in December, to 1.51 million ...

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

The Covid-19 pandemic catalysed the digital health revolution, including remote patient monitoring and mobile health.

In recent years, the oil and gas industry has progressed from using digital technologies for select use cases to making their ...

One driver is the introduction of drugs targeting unmet needs. The heart failure (HF) sector across the seven major markets is projected to reach $33.7b by 2032 at a compound annual growth rate of 9.6 ...

Data from the largest US Lyme disease registry suggests that 90% of PLD patients are excluded from clinical trials.

We recently compiled a list of the 10 Best Diabetes Stocks To Buy Under $10. In this article, we are going to take a look at ...

Novartis has recently announced that its intrathecal (IT) formulation of onasemnogene abeparvovec (OAV101 IT) successfully ...